Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Net Margin (2016 - 2021)

Corbus Pharmaceuticals Holdings has reported Net Margin over the past 7 years, most recently at 14257.07% for Q3 2021.

  • For Q3 2021, Net Margin fell 1149635.0% year-over-year to 14257.07%; the TTM value through Jun 2022 reached 45961.32%, down 4363525.0%, while the annual FY2021 figure was 6350.09%, 389388.0% down from the prior year.
  • Net Margin for Q3 2021 was 14257.07% at Corbus Pharmaceuticals Holdings, down from 12230.01% in the prior quarter.
  • Over five years, Net Margin peaked at 94.64% in Q4 2019 and troughed at 14257.07% in Q3 2021.
  • A 5-year average of 3679.42% and a median of 1404.73% in 2018 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: surged 872462bps in 2019 and later crashed -1332208bps in 2020.
  • Year by year, Net Margin stood at 868.18% in 2017, then crashed by -894bps to 8629.98% in 2018, then surged by 101bps to 94.64% in 2019, then tumbled by -1378bps to 1209.33% in 2020, then plummeted by -1079bps to 14257.07% in 2021.
  • Business Quant data shows Net Margin for CRBP at 14257.07% in Q3 2021, 12230.01% in Q2 2021, and 2379.38% in Q1 2021.